US Pharma MarketingEli Lilly is extending its push in neuroscience while the FDA wrestles with controversial peptide drugs.
Lilly’s leap into psychedelics; peptides in the spotlight
Lilly’s leap into psychedelics; peptides in the spotlight is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: PharmaVoice